LEMAITRE VASCULAR, INC. Operating Expenses
LEMAITRE VASCULAR, INC. (LMAT) reported Operating Expenses of $30.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. operating expenses for the quarter ending 2026-06-30 was $30.36M, a 5.32% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating expenses for the quarter ending 2026-03-31 was $30.62M, a 6.35% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating expenses for the quarter ending 2025-12-31 was $27.36M, a 6.30% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating expenses for the quarter ending 2025-09-30 was $25.64M, a 6.71% increase year-over-year.
- LEMAITRE VASCULAR, INC. operating expenses for fiscal 2025 was $110.63M, a 12.15% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. operating expenses for fiscal 2024 was $98.64M, a 9.20% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. operating expenses for fiscal 2023 was $90.34M, a 15.72% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. operating expenses for fiscal 2022 was $78.07M, a 20.18% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.36M 10-Q · filed 2026-08-05 | $60.99M 10-Q · filed 2026-08-05 | $88.34M derived: sum of 3 quarters · filed 2026-08-05 | $113.99M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $30.62M 10-Q · filed 2026-05-06 | $57.98M derived: sum of 2 quarters · filed 2026-05-06 | $83.62M derived: sum of 3 quarters · filed 2026-05-06 | $112.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $27.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $53.00M derived: sum of 2 quarters · filed 2026-02-26 | $81.83M derived: sum of 3 quarters · filed 2026-08-05 | $110.63M 10-K · filed 2026-02-26 |
| 2025-09-30 | $25.64M 10-Q · filed 2025-11-07 | $54.48M derived: sum of 2 quarters · filed 2026-08-05 | $83.27M 10-Q · filed 2025-11-07 | $109.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $28.83M 10-Q · filed 2026-08-05 | $57.63M 10-Q · filed 2026-08-05 | $83.36M derived: sum of 3 quarters · filed 2026-08-05 | $107.39M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $28.79M 10-Q · filed 2026-05-06 | $54.53M derived: sum of 2 quarters · filed 2026-05-06 | $78.56M derived: sum of 3 quarters · filed 2026-05-06 | $102.65M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $25.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $49.77M derived: sum of 2 quarters · filed 2026-02-26 | $73.85M derived: sum of 3 quarters · filed 2026-02-26 | $98.64M 10-K · filed 2026-02-26 |
| 2024-09-30 | $24.03M 10-Q · filed 2025-11-07 | $48.12M derived: sum of 2 quarters · filed 2025-11-07 | $72.91M 10-Q · filed 2025-11-07 | $95.97M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $24.09M 10-Q · filed 2025-08-06 | $48.88M 10-Q · filed 2025-08-06 | $71.94M derived: sum of 3 quarters · filed 2026-02-26 | $93.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $24.79M 10-Q · filed 2025-05-08 | $47.85M derived: sum of 2 quarters · filed 2026-02-26 | $69.48M derived: sum of 3 quarters · filed 2026-02-26 | $92.12M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $23.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $44.69M derived: sum of 2 quarters · filed 2026-02-26 | $67.33M derived: sum of 3 quarters · filed 2026-02-26 | $90.34M 10-K · filed 2026-02-26 |
| 2023-09-30 | $21.64M 10-Q · filed 2024-11-08 | $44.27M derived: sum of 2 quarters · filed 2024-11-08 | $67.28M 10-Q · filed 2024-11-08 | $86.36M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $22.63M 10-Q · filed 2024-08-08 | $45.64M 10-Q · filed 2024-08-08 | $64.73M derived: sum of 3 quarters · filed 2025-02-28 | $83.65M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $23.01M 10-Q · filed 2024-05-10 | $42.10M derived: sum of 2 quarters · filed 2025-02-28 | $61.02M derived: sum of 3 quarters · filed 2025-02-28 | $83.04M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $19.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $38.01M derived: sum of 2 quarters · filed 2025-02-28 | $60.03M derived: sum of 3 quarters · filed 2025-02-28 | $78.07M 10-K · filed 2025-02-28 |
| 2022-09-30 | $18.92M 10-Q · filed 2023-11-07 | $40.95M derived: sum of 2 quarters · filed 2023-11-07 | $58.98M 10-Q · filed 2023-11-07 | $76.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $22.03M 10-Q · filed 2023-08-08 | $40.06M 10-Q · filed 2023-08-08 | $57.72M derived: sum of 3 quarters · filed 2024-02-29 | $73.51M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $18.03M 10-Q · filed 2023-05-09 | $35.69M derived: sum of 2 quarters · filed 2024-02-29 | $51.48M derived: sum of 3 quarters · filed 2024-02-29 | $67.14M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $17.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $33.45M derived: sum of 2 quarters · filed 2024-02-29 | $49.10M derived: sum of 3 quarters · filed 2024-02-29 | $64.96M 10-K · filed 2024-02-29 |
| 2021-09-30 | $15.79M 10-Q · filed 2022-11-08 | $31.45M derived: sum of 2 quarters · filed 2022-11-08 | $47.30M 10-Q · filed 2022-11-08 | $62.16M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $15.65M 10-Q · filed 2022-08-05 | $31.51M 10-Q · filed 2022-08-05 | $46.37M derived: sum of 3 quarters · filed 2023-03-01 | $59.05M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $15.85M 10-Q · filed 2022-05-10 | $30.71M derived: sum of 2 quarters · filed 2023-03-01 | $43.40M derived: sum of 3 quarters · filed 2023-03-01 | $55.55M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $14.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $27.54M derived: sum of 2 quarters · filed 2023-03-01 | $39.70M derived: sum of 3 quarters · filed 2023-03-01 | $55.83M 10-K · filed 2023-03-01 |
| 2020-09-30 | $12.69M 10-Q · filed 2021-11-04 | $24.84M derived: sum of 2 quarters · filed 2021-11-04 | $40.97M 10-Q · filed 2021-11-04 | $55.95M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $12.16M 10-Q · filed 2021-08-05 | $28.29M 10-Q · filed 2021-08-05 | $43.27M derived: sum of 3 quarters · filed 2022-02-28 | $57.53M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $16.13M 10-Q · filed 2021-05-10 | $31.11M derived: sum of 2 quarters · filed 2022-02-28 | $45.37M derived: sum of 3 quarters · filed 2022-02-28 | $59.77M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $14.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $29.24M derived: sum of 2 quarters · filed 2022-02-28 | $43.64M derived: sum of 3 quarters · filed 2022-02-28 | $58.67M 10-K · filed 2022-02-28 |
| 2019-09-30 | $14.26M 10-Q · filed 2020-11-06 | $28.66M derived: sum of 2 quarters · filed 2020-11-06 | $43.69M 10-Q · filed 2020-11-06 | $55.72M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $14.40M 10-Q · filed 2020-08-06 | $29.43M 10-Q · filed 2020-08-06 | $41.45M derived: sum of 3 quarters · filed 2021-03-12 | $54.10M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $15.03M 10-Q · filed 2020-05-08 | $27.05M derived: sum of 2 quarters · filed 2021-03-12 | $39.70M derived: sum of 3 quarters · filed 2021-03-12 | $47.15M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $12.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $24.67M derived: sum of 2 quarters · filed 2021-03-12 | $32.12M derived: sum of 3 quarters · filed 2021-03-12 | $45.73M 10-K · filed 2021-03-12 |
| 2018-09-30 | $12.64M 10-Q · filed 2019-11-08 | $20.09M derived: sum of 2 quarters · filed 2019-11-08 | $33.70M 10-Q · filed 2019-11-08 | $45.63M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $7.45M 10-Q · filed 2018-08-06 | $21.06M 10-Q · filed 2019-08-06 | $32.99M derived: sum of 3 quarters · filed 2020-03-12 | $45.52M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $13.61M 10-Q · filed 2019-05-06 | $25.54M derived: sum of 2 quarters · filed 2020-03-12 | $38.07M derived: sum of 3 quarters · filed 2020-03-12 | $50.05M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $11.93M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $24.45M derived: sum of 2 quarters · filed 2020-03-12 | $36.43M derived: sum of 3 quarters · filed 2020-03-12 | $49.59M 10-K · filed 2020-03-12 |
| 2017-09-30 | $12.52M 10-Q · filed 2018-11-02 | $24.50M derived: sum of 2 quarters · filed 2018-11-02 | $37.66M 10-Q · filed 2018-11-02 | $49.95M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | $11.98M 10-Q · filed 2018-08-06 | $25.14M 10-Q · filed 2018-08-06 | $37.42M derived: sum of 3 quarters · filed 2019-03-11 | $49.10M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | $13.16M 10-Q · filed 2018-05-04 | $25.45M derived: sum of 2 quarters · filed 2019-03-11 | $37.12M derived: sum of 3 quarters · filed 2019-03-11 | $48.70M derived: sum of 4 quarters · filed 2019-03-11 |
| 2016-12-31 | $12.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $23.96M derived: sum of 2 quarters · filed 2019-03-11 | $35.54M derived: sum of 3 quarters · filed 2019-03-11 | $46.60M 10-K · filed 2019-03-11 |
| 2016-09-30 | $11.68M 10-Q · filed 2017-11-03 | $23.26M derived: sum of 2 quarters · filed 2017-11-03 | $34.31M 10-Q · filed 2017-11-03 | $45.63M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $11.58M 10-Q · filed 2017-08-03 | $22.64M 10-Q · filed 2017-08-03 | $33.95M derived: sum of 3 quarters · filed 2018-03-09 | $44.15M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $11.06M 10-Q · filed 2017-05-04 | $22.37M derived: sum of 2 quarters · filed 2018-03-09 | $32.56M derived: sum of 3 quarters · filed 2018-03-09 | $42.90M derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $11.31M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $21.51M derived: sum of 2 quarters · filed 2018-03-09 | $31.84M derived: sum of 3 quarters · filed 2018-03-09 | $42.65M 10-K · filed 2018-03-09 |
| 2015-09-30 | $10.20M 10-Q · filed 2016-11-04 | $20.53M derived: sum of 2 quarters · filed 2016-11-04 | $31.34M 10-Q · filed 2016-11-04 | $41.43M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $10.34M 10-Q · filed 2016-08-05 | $21.14M 10-Q · filed 2016-08-05 | $31.23M derived: sum of 3 quarters · filed 2017-03-09 | $41.38M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $10.81M 10-Q · filed 2016-05-06 | $20.90M derived: sum of 2 quarters · filed 2017-03-09 | $31.05M derived: sum of 3 quarters · filed 2017-03-09 | $41.44M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $10.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $20.24M derived: sum of 2 quarters · filed 2017-03-09 | $30.64M derived: sum of 3 quarters · filed 2017-03-09 | $42.09M 10-K · filed 2017-03-09 |
| 2014-09-30 | $10.15M 10-Q · filed 2015-11-06 | $20.55M derived: sum of 2 quarters · filed 2015-11-06 | $32.00M 10-Q · filed 2015-11-06 | $42.79M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $10.40M 10-Q · filed 2015-08-06 | $21.85M 10-Q · filed 2015-08-06 | $32.63M derived: sum of 3 quarters · filed 2016-03-10 | $42.58M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $11.46M 10-Q · filed 2015-05-07 | $22.24M derived: sum of 2 quarters · filed 2016-03-10 | $32.18M derived: sum of 3 quarters · filed 2016-03-10 | $41.97M derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $10.78M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $20.72M derived: sum of 2 quarters · filed 2016-03-10 | $30.51M derived: sum of 3 quarters · filed 2016-03-10 | $40.60M 10-K · filed 2016-03-10 |
| 2013-09-30 | $9.94M 10-Q · filed 2014-11-06 | $19.73M derived: sum of 2 quarters · filed 2014-11-06 | $29.81M 10-Q · filed 2014-11-06 | $39.32M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $9.79M 10-Q · filed 2014-08-07 | $19.87M 10-Q · filed 2014-08-07 | $29.38M derived: sum of 3 quarters · filed 2015-03-18 | $38.40M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $10.08M 10-Q · filed 2014-05-08 | $19.59M derived: sum of 2 quarters · filed 2015-03-18 | $28.61M derived: sum of 3 quarters · filed 2015-03-18 | $37.70M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $9.51M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $18.52M derived: sum of 2 quarters · filed 2015-03-18 | $27.61M derived: sum of 3 quarters · filed 2015-03-18 | $36.63M 10-K · filed 2015-03-18 |
| 2012-09-30 | $9.01M 10-Q · filed 2013-11-07 | $18.10M derived: sum of 2 quarters · filed 2013-11-07 | $27.12M 10-Q · filed 2013-11-07 | $35.81M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $9.09M 10-Q · filed 2013-08-09 | $18.11M 10-Q · filed 2013-08-09 | $26.80M derived: sum of 3 quarters · filed 2014-03-21 | $34.99M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $9.02M 10-Q · filed 2013-05-08 | $17.71M derived: sum of 2 quarters · filed 2014-03-21 | $25.90M derived: sum of 3 quarters · filed 2014-03-21 | $35.37M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $16.88M derived: sum of 2 quarters · filed 2014-03-21 | $26.36M derived: sum of 3 quarters · filed 2014-03-21 | $36.54M 10-K · filed 2014-03-21 |
| 2011-09-30 | $8.19M 10-Q · filed 2012-11-09 | $17.66M derived: sum of 2 quarters · filed 2012-11-09 | $27.85M 10-Q · filed 2012-11-09 | $39.49M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $9.47M 10-Q · filed 2012-08-10 | $19.65M 10-Q · filed 2012-08-10 | $31.30M derived: sum of 3 quarters · filed 2013-03-27 | $39.66M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | $10.18M 10-Q · filed 2012-05-03 | $21.82M derived: sum of 2 quarters · filed 2013-03-27 | $30.19M derived: sum of 3 quarters · filed 2013-03-27 | $38.84M derived: sum of 4 quarters · filed 2013-03-27 |
| 2010-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $20.01M derived: sum of 2 quarters · filed 2013-03-27 | $28.66M derived: sum of 3 quarters · filed 2013-03-27 | $37.70M 10-K · filed 2013-03-27 |
| 2010-09-30 | $8.37M 10-Q · filed 2011-11-14 | $17.01M derived: sum of 2 quarters · filed 2011-11-14 | $26.06M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $8.65M 10-Q · filed 2011-08-12 | $17.70M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $35.35M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |